oxidopamine and tacrolimus

oxidopamine has been researched along with tacrolimus in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's7 (87.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Connolly, MA; Fuller, M; Guo, H; Hamilton, GS; Howorth, P; Huang, W; Li, JH; Liang, S; Nowotnik, AC; Ramsey, C; Ross, DT; Sauer, H; Soni, R; Steiner, JP; Suzdak, PD; Valentine, HL1
Ichinose, H; Mogi, M; Nagatsu, T; Ogawa, N; Tanaka, K; Togari, A1
Dawson, TM; Dawson, VL; Guo, X1
Fujita, N; Miyazaki, I; Ogawa, N; Tanaka, K; Yoshioka, M1
Donnerer, J; Zuber, M1
Alemdar, AY; McAlister, VC; Mendez, I; Sadi, D1
Kääriäinen, T; Kulkarni, SK; Manáková, S; Männistö, PT; Singh, A; Taari, H1
Alemdar, AY; McAlister, V; Mendez, I; Sadi, D1

Other Studies

8 other study(ies) available for oxidopamine and tacrolimus

ArticleYear
Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models.
    Proceedings of the National Academy of Sciences of the United States of America, 1997, Mar-04, Volume: 94, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carrier Proteins; Cells, Cultured; Chickens; Disease Models, Animal; DNA-Binding Proteins; Dopamine Agents; Heat-Shock Proteins; Male; Mice; Nerve Crush; Nerve Regeneration; Nervous System Diseases; Neurites; Neurons; Oxidopamine; Parkinson Disease; Pyrrolidines; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Serotonin; Tacrolimus; Tacrolimus Binding Proteins; Tyrosine 3-Monooxygenase

1997
Increase in level of tumor necrosis factor-alpha in 6-hydroxydopamine-lesioned striatum in rats is suppressed by immunosuppressant FK506.
    Neuroscience letters, 2000, Aug-11, Volume: 289, Issue:3

    Topics: Animals; Dopamine; Functional Laterality; Immunosuppressive Agents; Male; Neostriatum; Neural Pathways; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tacrolimus; Tumor Necrosis Factor-alpha

2000
Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons.
    The European journal of neuroscience, 2001, Volume: 13, Issue:9

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Brain Injuries; Cells, Cultured; Dopamine; Immunophilins; Immunosuppressive Agents; Ligands; Mesencephalon; Mice; Mice, Knockout; Nerve Degeneration; Nerve Regeneration; Neurons; Neuroprotective Agents; Neurotoxins; Oxidopamine; Parkinsonian Disorders; Pyrrolidines; Rats; Rats, Sprague-Dawley; Tacrolimus; Tacrolimus Binding Protein 1A; Tyrosine 3-Monooxygenase

2001
GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum.
    Neuroscience letters, 2002, Mar-15, Volume: 321, Issue:1-2

    Topics: Animals; Antioxidants; Catalase; Dopamine; Dopamine Agents; Glutamate-Cysteine Ligase; Glutathione; Glutathione Peroxidase; Glutathione Transferase; Immunophilins; Immunosuppressive Agents; Male; Mice; Mice, Inbred ICR; Neostriatum; Neurons; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Pyrrolidines; Superoxide Dismutase; Tacrolimus

2002
Effect of FK506 on neurotransmitter content and expression of GAP-43 in neurotoxin-lesioned peripheral sensory and sympathetic neurons.
    Pharmacology, 2002, Volume: 66, Issue:1

    Topics: Analysis of Variance; Animals; Calcitonin Gene-Related Peptide; Capsaicin; Ganglia, Sympathetic; GAP-43 Protein; Heart Atria; Immunosuppressive Agents; In Situ Hybridization; Male; Neurons, Afferent; Neurotoxins; Neurotransmitter Agents; Organ Specificity; Oxidopamine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spinal Cord; Tacrolimus

2002
Liposomal formulations of tacrolimus and rapamycin increase graft survival and fiber outgrowth of dopaminergic grafts.
    Cell transplantation, 2004, Volume: 13, Issue:3

    Topics: Adrenergic Agents; Animals; Brain; Cell Growth Processes; Cell Survival; Cell Transplantation; Dopamine; Female; Immunohistochemistry; Immunosuppressive Agents; Liposomes; Mesencephalon; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Sirolimus; Tacrolimus; Tyrosine 3-Monooxygenase; Water

2004
Failure of FK506 (tacrolimus) to alleviate apomorphine-induced circling in rat Parkinson model in spite of some cytoprotective effects in SH-SY5Y dopaminergic cells.
    Brain research, 2005, Mar-15, Volume: 1038, Issue:1

    Topics: Animals; Apomorphine; Behavior, Animal; Caspase 3; Caspases; Cell Death; Cell Line, Tumor; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Immunophilins; Male; Motor Activity; Nerve Degeneration; Neuroblastoma; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Random Allocation; Rats; Rats, Wistar; Tacrolimus

2005
Intracerebral co-transplantation of liposomal tacrolimus improves xenograft survival and reduces graft rejection in the hemiparkinsonian rat.
    Neuroscience, 2007, Apr-25, Volume: 146, Issue:1

    Topics: Analysis of Variance; Animals; Antigens, CD; Behavior, Animal; Cell Transplantation; Disease Models, Animal; Embryo, Mammalian; Female; Immunosuppressive Agents; Liposomes; Mice; Mice, Inbred C57BL; Motor Activity; Oxidopamine; Parkinsonian Disorders; Rats; Tacrolimus; Time Factors; Transplantation, Heterologous; Tyrosine 3-Monooxygenase

2007